The upgrade from Neutral to Buy and the substantial increase in the price target from $0.5 to $13 by B. Riley Securities is likely to positively impact Core Scientific's stock price in the short term. Such a significant change in analyst rating and price target typically boosts investor confidence and can lead to increased buying activity.